Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: Effect of the Use of Continuous Glucose Monitoring Versus Standard Glycemic Control in Hospitalized Patients with Type 2 Diabetes. [NA]
A completed clinical trial evaluating continuous glucose monitoring versus standard glycemic control in hospitalized patients with Type 2 di…
-
EMA approval · 2024-09-23EMA Authorised: Repaglinide Accord (repaglinide) — Accord Healthcare S.L.U.
The European Medicines Agency authorised Accord Healthcare S.L.U.'s Repaglinide Accord for the treatment of type 2 diabetes mellitus.
-
CLINICAL_TRIALS research · 2024-09-23Clinical Trial Update: Better Risk Perception Via Patient Similarity to Control Hyperglycemia and Sustained by Telemonitoring [NA]
Clinical trial update for a study in Type 2 diabetes exploring risk perception using patient similarity and improving glycemic control throu…
-
CLINICAL_TRIALS trial_result · 2024-09-20Clinical Trial Update: Optimizing In-hospital Use of Evidence-based Therapies for Patients With Cardio-Renal-Metabolic Disease [NA]
This clinical trial update reports completion of a study focused on optimizing in-hospital use of evidence-based therapies for patients with…
-
CLINICAL_TRIALS research · 2024-09-20Clinical Trial Update: The Progress of Diabetes After Supaglutide Treatment in Type 2 Diabetes Patients
A clinical trial evaluating the effects of Supaglutide on diabetes progression in patients with Type 2 diabetes mellitus; the study is curre…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Lanifibranor in Patients With Type 2 Diabetes & Nonalcoholic Fatty Liver Disease [Phase 2]
Phase 2 trial of lanifibranor in patients with nonalcoholic fatty liver disease and type 2 diabetes completed; results posted.
-
CLINICAL_TRIALS safety_alert · 2024-09-19Clinical Trial Update: Safety of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Among Patients With Type 2 Diabetes
A completed clinical trial update notes safety signals associated with SGLT2 inhibitors in adults with type 2 diabetes, including risks of u…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Evaluating Comparative Effectiveness of Empagliflozin in Type 2 Diabetes Population With and Without Chronic Kidney Disease
Clinical trial update reporting results from a completed study evaluating the comparative effectiveness of empagliflozin in adults with type…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A Research Study Looking at the Comparability of 2 Different Forms of Oral Semaglutide in Healthy People [Phase 1]
A Phase 1 trial comparing two formulations of oral semaglutide to assess their pharmacokinetic comparability in healthy volunteers and peopl…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Metabolic Effects of Duodenal Jejunal Bypass Liner for Type 2 Diabetes Mellitus
A completed clinical trial update examining the metabolic effects of the duodenal-jejunal bypass liner in individuals with type 2 diabetes m…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors and Risk of Cardiovascular Events
A clinical trial update evaluating SGLT2 inhibitors and cardiovascular event risk in type 2 diabetes, reporting outcomes such as myocardial …
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Outcome of Complete Pulpotomy in Healthy and Type 2 Diabetic Patients in Permanent Teeth with Irreversible Pulpitis [NA]
This clinical trial update reports the outcomes of complete pulpotomy in healthy individuals and in patients with Type 2 diabetes mellitus w…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Effect of Glucagon and Glucagon-like Peptide-1 Co-agonism on Cardiac Function and Metabolism in Overweight Participants with Type 2 Diabetes [Phase 4]
A Phase 4 trial evaluated the effects of a glucagon and glucagon-like peptide-1 co-agonist on cardiac function and metabolism in overweight …
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Patient Preference Study in Type-2 Diabetes Mellitus: Discrete Choice Experiment (DCE) to Support Novo Nordisk's Long-Acting Insulin
Novo Nordisk completed a patient preference study using a discrete choice experiment to inform its long-acting insulin development for Type …
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Using Technology to Share Fitness Goals and Results to Improve Diabetes Outcomes [NA]
This completed clinical trial evaluates whether technology-enabled sharing of fitness goals and progress can improve outcomes in Type 2 Diab…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A Research Study, Looking at the Characterization of Treatment Intensified (Add on to Metformin) Real-world Adult Population With Type 2 Diabetes Mellitus in India, Pakistan and Thailand.
A completed clinical trial evaluating intensified treatment added to metformin in adults with type 2 diabetes across India, Pakistan, and Th…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Clinical Utility of a Genomic Predictor Test on the Management of Cardiorenal Complications of Type 2 Diabetes [NA]
This clinical trial update describes an ongoing study evaluating the clinical utility of a genomic predictor test in managing cardiorenal co…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: PrevaLence of Albuminuria in Patients With CARdiovascular Disease and Type 2 Diabetes Mellitus in China: a National Cross-sectional Study
A national cross-sectional study in China assessing how prevalent albuminuria is among patients with cardiovascular disease and type 2 diabe…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes in India
A completed clinical trial in India evaluating how oral semaglutide works in adults with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A Research Study, Looking at How Ryzodeg® (Insulin Degludec/Insulin Aspart) Works in People With Type 2 Diabetes in Local Clinical Practice
A completed clinical trial evaluating how Ryzodeg (insulin degludec/insulin aspart) works in people with type 2 diabetes in local clinical p…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Integration of a Trained Language Model to Improve Glycemic Control Through Increased Physical Activity: a Fully Digital My Heart Counts Smartphone App Randomized Trial [NA]
A randomized trial evaluating a trained language model integrated into a digital smartphone app (My Heart Counts) to improve glycemic contro…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A Trial to Assess Steviol Glycosides on Acute Appetite Hormone Release [NA]
This document reports that a clinical trial evaluating the effects of steviol glycosides on acute appetite hormone release has completed. Th…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control As a Means of Improving Glycemic Control in Adults with Type 2 Diabetes Mellitus [NA]
Completed clinical trial evaluating Electrical Vestibular Nerve Stimulation (VeNS) versus sham for glycemic control in adults with Type 2 di…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Household Participants [NA]
A clinical trial update from the University of Hawaii notes a household participants study not yet recruiting, evaluating conditions includi…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Effect of CGM on Glucose Control in Non-insulin-treated Patients with Type 2 Diabetes Mellitus [NA]
A clinical trial is evaluating whether continuous glucose monitoring improves glucose control in adults with Type 2 diabetes who are not tre…